International Journal of Molecular Sciences (Feb 2022)

Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients—A Target for SARS-CoV-2 Propagation

  • Veronica Ferrucci,
  • Pasqualino de Antonellis,
  • Fabrizio Quarantelli,
  • Fatemeh Asadzadeh,
  • Francesca Bibbò,
  • Roberto Siciliano,
  • Carmen Sorice,
  • Ida Pisano,
  • Barbara Izzo,
  • Carmela Di Domenico,
  • Angelo Boccia,
  • Maria Vargas,
  • Biancamaria Pierri,
  • Maurizio Viscardi,
  • Sergio Brandi,
  • Giovanna Fusco,
  • Pellegrino Cerino,
  • Livia De Pietro,
  • Ciro Furfaro,
  • Leonardo Antonio Napolitano,
  • Giovanni Paolella,
  • Lidia Festa,
  • Stefania Marzinotto,
  • Maria Concetta Conte,
  • Ivan Gentile,
  • Giuseppe Servillo,
  • Francesco Curcio,
  • Tiziana de Cristofaro,
  • Francesco Broccolo,
  • Ettore Capoluongo,
  • Massimo Zollo

DOI
https://doi.org/10.3390/ijms23041941
Journal volume & issue
Vol. 23, no. 4
p. 1941

Abstract

Read online

The development of prophylactic agents against the SARS-CoV-2 virus is a public health priority in the search for new surrogate markers of active virus replication. Early detection markers are needed to follow disease progression and foresee patient negativization. Subgenomic RNA transcripts (with a focus on sgN) were evaluated in oro/nasopharyngeal swabs from COVID-19-affected patients with an analysis of 315 positive samples using qPCR technology. Cut-off Cq values for sgN (Cq O-methyl antisense RNA (related to the sgN sequence) can impair SARS-CoV-2 N protein synthesis, viral replication, and syncytia formation in human cells (i.e., HEK-293T cells overexpressing ACE2) upon infection with VOC Alpha (B.1.1.7)-SARS-CoV-2 variant, defining the use that this procedure might have for future therapeutic actions against SARS-CoV-2.

Keywords